Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007
Date:11/13/2007

. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.

Forward-looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, statements related to research and development programs, plans for 2007 and 2008, expectations regarding the timing of the filing of INDs and commencement of IND enabling activities and preclinical and clinical studies, partnership opportunities, the potential of the Company's inhibitors as treatments for certain cancers, partnering opportunities for the Company's research and development programs and the ability to discover, develop and commercialize cancer therapeutics. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug discovery, development and commercialization, which include, without limitation, the potential failure of development candidates to advance through preclinical studies or demonstrate safety and efficacy in clinical testing and the ability to file INDs or commence IND enabling activities or preclinical or clinical studies in the referenced time frames. The results of early preclinical studies or clinical trials may not be predictive of future results, and the Company cannot provide any assurances that any of its compounds or development candidates will have favorable results in preclinical studies or future clinical trials. In addition, results may be affected by risks related to the implementation of its collaborations, the failure to successfully complete collaborations
'/>"/>

SOURCE SGX Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... WOODLAND HILLS, CA (PRWEB) November 26, 2014 ... implants costing thousands of dollars, the prosthodontists at the Anacapa ... that paying for dental procedures can be daunting for some. ... to pay for the procedures they offer. , “No dentist ... functioning and beautiful set of teeth,” said Dr. Mamaly Reshad, ...
(Date:11/26/2014)... Howell, NJ (PRWEB) November 26, 2014 ... issues,” and Florida-based SeniorNet, a nonprofit organization providing the ... have teamed up to help seniors navigate the rough ... will focus on educating seniors on the topic of ... through the somewhat complicated process of applying for this ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a ... award the 2014 Lync Pioneer Award ... as a great honor to ISI, who continues ... Specifically, ISI offers an integrated collaboration reporting and ... including voice, video, Lync IM, and conferencing. ...
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with ... sales(at)researchmoz(dot)us , Researchmoz.us announces a new research report ... deep study of the report on the diabetes topic ... The global glucose monitoring market has a growth rate ... diabetics in the world. Their numbers have prompted the ...
(Date:11/26/2014)... 26, 2014 Bunion Bootie, the newest ... in an early celebration of the early holiday shopping ... offered at the promotional price of $29.95 each (normally ... addition to any automatic discounts applied when buying more ... website for complete details. It’s simple: purchasing more ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2
... small Pacific Islands, which consists of the some of ... the global conservation map//, and is said to be ... ,Martin Puta Tofinga, Minister of Environment, ... announced the establishment of the Phoenix Islands Protected Area ...
... under the Freedom of Information Act have revealed that hospitals ... use of car parks. The BBC reports that trusts had ... this service. ,The hospitals, which earned the maximum ... The Department of Health figures show that University Hospital Birmingham ...
... in the April issue of Radiology says that ultrasound is ... and also assess// the effectiveness of chemotherapy. Researchers at the ... a study where they examined the largest group of women ... cancer during pregnancy. ,"Ultrasound identified 100 percent of ...
... that promotes body growth, is produced in the brain according ... // The researchers have been able to trace the origin ... the brain in charge of memory and emotion – called ... the fact that more growth hormones are produced in females ...
... on cancer have proposed that cancer patients should be ... their care. // ,National standards in the ... standards could be enforced by the National Institute of ... the aspects of cancer services that would be standardized ...
... alcohol is not a sign that drinkers remain uninfluenced by ... like red bull after alcohol, to maintain sobriety. // ... after drinking vodka mixed with red bull felt less drunk, ... Souza-Formigoni, PhD, in a news release said “The person is ...
Cached Medicine News:Health News:Phoenix Islands To Be Protected Under Global Conservation Map 2Health News:Phoenix Islands To Be Protected Under Global Conservation Map 3Health News:Charging Car Park Fees From Cancer Patients Is Morally Wrong, Says Macmillan Cancer Relief 2Health News:Ultrasound Can Detect Breast Cancer in Pregnant Women 2Health News:Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety? 2
(Date:11/24/2014)... -- Marta Rendon, MD, founder of the Rendon Center for Dermatology ... international key opinion leader in dermatology, was one of only ... to attend the international Aesthetic Experts Summit held ... at this gathering of over 600 physicians from 57 countries, ... experts from Asia and ...
(Date:11/24/2014)...  AiCure, an artificial intelligence company providing advanced ... ingestion, has announced the start of a major ... receiving medication as maintenance therapy for opioid addiction. ... have quadrupled in the last 15 years. Opioids ... cocaine and benzodiazepines combined. Overall, the economic cost ...
(Date:11/24/2014)... 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... the board of directors and from his positions as chairman ... recently serving as the company,s president and chief operating officer, ... the board of directors.  Gary Lyons , a member ... Mr. Gower is expected to remain an employee until the ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Can artificial intelligence solve the $55 billion problem of opioid abuse? 2Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3
... FRIMLEY, England, May 20 , - Tasigna(R) ... to Prior Treatment in the Chronic (Early) Phase ... Nature of Tasigna(R) Tackles the Root Cause of ... - Tasigna Expands CML Portfolio for Novartis, ...
... Similar to, Native Bladder by Six Months; Data Presented at May ... ... Session, ORLANDO, Fla. and EAST NORRITON, Pa., May 19 ... and neo-vessels, presented preclinical efficacy data for its,Tengion Neo-Bladder Replacement(TM) at ...
Cached Medicine Technology:Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 2Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 3Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 4Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 5Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2
Merocel Ophthalmic Products provide the surgeon with fiber free products for fluid,control and safe cleaning of fine microsurgical instruments. The exclusive Merocel,material is highly absorbent,...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Medicine Products: